John Roback MD, PhD

John Roback MD, PhD

Founder, Director

Dr. Roback is currently a tenured Professor in the Department of Pathology and Laboratory Medicine, Director of the Emory Center for Transfusion and Cellular Therapies, Director of the Emory University Hospital Blood Bank, and Director of the Stem Cell Processing Laboratory at Emory University Hospital, Vice-Chair of Clinical Pathology, and Medical Director of Emory Medical Laboratories. Dr. Roback currently serves as the Co-Chairman of the NIH/NHLBI Global Blood Safety and Availability Strategic Planning Committee, Chairman of the AABB Clinical Transfusion Medicine Committee, and Editor of the AABB Technical Manual.

The focus of Dr. Roback’s laboratory is basic and translational research investigations with an emphasis on improved transfusion medicine clinical practice. The primary ongoing projects that have been or are currently NIH-funded include: 1) Utilization of murine models of lethal murine cytomegalovirus (MCMV) disease to develop improved, clinically applicable methods for adoptive antiviral immunotherapy and post-transplant vaccination to for bone marrow transplant recipients; 2) Development of novel, innovative methods and devices to perform pretransfusion testing of blood components; and 3) Development of improved PCR methods for screening blood and hematopoietic stem cell products for CMV infectivity.

Dr. Roback received an MD from University of Chicago Pritzker School of Medicine in Chicago, IL and a PhD in Experimental Pathology from The University of Chicago in Chicago, IL. For his post-doctoral training, he completed a Residency at Albert Einstein College of Medicine in Bronx, NY and Emory University School of Medicine in Atlanta, GA. He completed his Fellowship at Emory University School of Medicine in Atlanta, GA. Dr. Roback received a Bachelor of Arts in Biophysics from Johns Hopkins University.